Table 1. Summary of patient characteristics, MRI data and volumetric parameters for the 40 patients included in the study.

Patient characteristics
Age (median, range)	64 (36–74)
Sex	21 Male (52.50%)
	19 Female (47.50%)
Survival (median, range)	10.78 months (2.30–52.33)
Treatment group	17 Temozolomide+Bevacizumab (42.50%)
	23 Temozolomide (57.50%)
MRI characteristics (mean and range)
Pixel spacing (mm)	0.67 (0.43–1.04)
Slice thickness (mm)	2.54 (0.80–6.00)
Slices per patient	142 (16–301)
Relevant volumetric parameters (mean and range)
Tumor volume (V) (cm3)	28.32 (0.99–79.23)
Contrast enhancing volume (VCE) (cm3)	19.99 (0.99–68.11)
Maximal tumor diameter (cm)	5.55 (1.48–10.57)
Spherical rim width (cm)	0.67 (0.25–2.07)